Significance of Molecular Identification and Antifungal Susceptibility of Clinically Significant Yeasts and Moulds in a Global Antifungal Surveillance Programme

Mycopathologia

Volumn 174, Issue 4, 2012, Pages 259-271

  Pfaller, Michael A ^a   Woosley, Leah N ^a   Messer, Shawn A ^a   Jones, Ronald N ^a   Castanheira, Mariana ^a  

^a JMI LABORATORIES   (United States)

Author keywords

Fungi; Molecular identification methods; SENTRY

Indexed keywords

ASPERGILLUS; ASPERGILLUS FUMIGATUS; CANDIDA; CANDIDA ALBICANS; CANDIDA DUBLINIENSIS; CANDIDA GLABRATA; FUNGI; FUSARIUM; TRICHOSPORON (UNCLASSIFIED);

EID: 84866294024     PISSN: 0301486X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11046-012-9551-x     Document Type: Article

References (36)

1. Cortez KJ, Roilides E, Quiroz-Telles F, et al. Infections caused by Scedosporium spp. Clin Microbiol Rev. 2008; 21: 157-97.
2. Johnson EM. Rare and emerging Candida species. Curr Fungal Infect Rep. 2009; 3: 152-9.
3. Miceli MH, Diaz JA, Lee SA. Emerging opportunistic yeast infections. Lancet Infect Dis. 2011; 11: 142-51.
4. Pfaller MA, Diekema DJ, Merz WG. Infections due to emerging non-Candida, non-Cryptococcus opportunistic yeast pathogens. Curr Fungal Infect Rep. 2007; 1: 53-64.
5. Pfaller MA, Diekema DJ. Epidemiology of invasive mycoses in North America. Crit Rev Microbiol. 2010; 36: 1-53.
6. Sutton DA. Rare and emerging agents of hyalohyphomycosis. Curr Fungal Infet Reports. 2008; 2: 134-142.
7. Alexander BD, Pfaller MA. Contemporary tools for the diagnosis and management of invasive mycoses. Clin Infect Dis. 2006; 43: S15-27.
8. Balajee SA, Borman AM, Brandt ME, et al. Sequence-based identification of Aspergillus, Fusarium, and Mucorales species in the clinical mycology laboratory: Where are we and where should we go from here? J Clin Microbiol. 2009; 47: 877-84.
9. Linton CJ, Borman AM, Cheung G, et al. Molecular identification of unusual pathogenic yeast isolates by large ribosomal subunit gene sequencing: 2 years of experience at the United kingdom mycology reference laboratory. J Clin Microbiol. 2007; 45: 1152-8.
10. Pounder JI, Simmon KE, Barton CA, Hohmann SL, Brandt ME, Petti CA. Discovering potential pathogens among fungi identified as nonsporulating molds. J Clin Microbiol. 2007; 45: 568-71.
11. Etienne KA, Gade L, Lockhart SR, et al. Screening of a large global Aspergillus fumigatus species complex collection by using a species-specific microsphere-based Luminex assay. J Clin Microbiol. 2009; 47: 4171-2.
12. Pfaller MA, Castanheira M, Diekema DJ, Messer SA, Jones RN. Triazole and echinocandin wild-type MIC distributions with epidemiological cutoff values for six uncommon species of Candida. J Clin Microbiol. 2011; 49: 3800-4.
13. Cendejas-Bueno E, Gomez-Lopez A, Mellado E, Rodriguez-Tudela JL, Cuenca-Estrella M. Identification of pathogenic rare yeast species in clinical samples: comparison between phenotypical and molecular methods. J Clin Microbiol. 2010; 48: 1895-9.
14. Latouche GN, Daniel HM, Lee OC, Mitchell TG, Sorrell TC, Meyer W. Comparison of use of phenotypic and genotypic characteristics for identification of species of the anamorph genus Candida and related teleomorph yeast species. J Clin Microbiol. 1997; 35: 3171-80.
15. Meletiadis J, Arabatzis M, Bobola M, et al. Comparative evaluation of three commercial identification systems using common and rare bloodstream yeast isolates. J Clin Microbiol. 2011; 49: 2722-7.
16. Sanguinetti M, Porta R, Sali M, et al. Evaluation of VITEK 2 and RapID yeast plus systems for yeast species identification: experience at a large clinical microbiology laboratory. J Clin Microbiol. 2007; 45: 1343-6.
17. Burton MJ, Shah P, Swiatlo E. Misidentification of Candida parapsilosis as C. famata in a clinical case of vertebral osteomyelitis. Am J Med Sci. 2011; 341: 71-3.
18. Jensen RH, Arendrup MC. Candida palmioleophila: Characterization of a previously overlooked pathogen and its unique susceptibility profile in comparison with five related species. J Clin Microbiol. 2011; 49: 549-56.
19. Lockhart SR, Messer SA, Pfaller MA, Diekema DJ. Identification and susceptibility profile of Candida fermentati from a worldwide collection of Candida guilliermondii clinical isolates. J Clin Microbiol. 2009; 47: 242-4.
20. Lockhart SR, Messer SA, Pfaller MA, Diekema DJ. Geographic distribution and antifungal susceptibility of the newly described species Candida orthopsilosis and Candida metapsilosis in comparison to the closely related species Candida parapsilosis. J Clin Microbiol. 2008; 46: 2659-64.
21. Wang H, Xiao M, Kong F, et al. Accurate and practical identification of 20 Fusarium species by seven-locus sequence analysis and reverse line blot hybridization, and an in vitro antifungal susceptibility study. J Clin Microbiol. 2011; 49: 1890-8.
22. Borman AM, Linton CJ, Miles SJ, Johnson EM. Molecular identification of pathogenic fungi. J Antimicrob Chemother. 2008; 61(Suppl 1): i7-12.
23. Leaw SN, Chang HC, Sun HF, Barton R, Bouchara JP, Chang TC. Identification of medically important yeast species by sequence analysis of the internal transcribed spacer regions. J Clin Microbiol. 2006; 44: 693-9.
24. Gilgado F, Cano J, Gene J, Guarro J. Molecular phylogeny of the Pseudallescheria boydii species complex: proposal of two new species. J Clin Microbiol. 2005; 43: 4930-42.
25. O'Donnell K, Sutton DA, Fothergill A, et al. Molecular phylogenetic diversity, multilocus haplotype nomenclature, and in vitro antifungal resistance within the Fusarium solani species complex. J Clin Microbiol. 2008; 46: 2477-90.
26. CLSI. M27-A3. Reference method for broth dilution antifungal susceptibility testing of yeasts. 3rd ed. Wayne, PA: Clinical and Laboratory Standards Institute; 2008.
27. Pfaller MA, Andes D, Arendrup MC, et al. Clinical breakpoints for voriconazole and Candida spp. revisited: Review of microbiologic, molecular, pharmacodynamic, and clinical data as they pertain to the development of species-specific interpretive criteria. Diagn Microbiol Infect Dis. 2011; 70: 330-43.
28. CLSI. M38-A2. Reference method for broth dilution antifungal susceptibility testing of filamentous fungi. 2nd ed. Wayne, PA: Clinical and Laboratory Standards Institute; 2008.
29. CLSI. M27-S3. Reference method for broth dilution antifungal susceptibility testing of yeasts: 3rd Informational Supplement. Wayne, PA: Clinical and Laboratory Standards Institute; 2008.
30. Pfaller MA, Andes D, Diekema DJ, Espinel-Ingroff A, Sheehan D. Testing TCSfA. Wild-type MIC distributions, epidemiological cutoff values and species-specific clinical breakpoints for fluconazole and Candida: Time for harmonization of CLSI and EUCAST broth microdilution methods. Drug Resist Updat. 2010; 13: 180-95.
31. Pfaller MA, Boyken L, Hollis RJ, et al. Wild-type MIC distributions and epidemiological cutoff values for the echinocandins and Candida spp. J Clin Microbiol. 2010; 48: 52-6.
32. Pfaller MA, Diekema DJ, Andes D, et al. Clinical breakpoints for the echinocandins and Candida revisited: Integration of molecular, clinical, and microbiological data to arrive at species-specific interpretive criteria. Drug resist Updat. 2011; 14: 164-76.
33. Pfaller MA, Boyken L, Hollis RJ, et al. Wild-type MIC distributions and epidemiological cutoff values for posaconazole and voriconazole and Candida spp. as determined by 24-hour CLSI broth microdilution. J Clin Microbiol. 2011; 49: 630-7.
34. Pfaller MA, Castanheira M, Messer SA, Moet GJ, Jones RN. Echinocandin and triazole antifungal susceptibility profiles for Candida spp., Cryptococcus neoformans, and Aspergillus fumigatus: application of new CLSI clinical breakpoints and epidemiologic cutoff values to characterize resistance in the SENTRY Antimicrobial Surveillance Program (2009). Diagn Microbiol Infect Dis. 2011; 69: 45-50.
35. Underwood A, Green J. Call for a quality standard for sequence-based assays in clinical microbiology: Necessity for quality assessment of sequences used in microbial identification and typing. J Clin Microbiol. 2011; 49: 23-6.
36. Howard SJ, Arendrup MC. Acquired antifungal drug resistance in Aspergillus fumigatus: Epidemiology and detection. Med Mycol. 2010; 49(Suppl 1): S90-5.